Novo Nordisk Settles Patent Dispute With Pfizer
Pharmaceutical company Novo Nordisk Inc. has reached a settlement in a patent dispute with rival drug maker Pfizer Inc. over the diabetes treatment Exubera, the company said in a statement released...To view the full article, register now.
Already a subscriber? Click here to view full article